PAPER Christenson PR, Jeong H, Li M, Ahn H, Schmeichel AM, Misra P, Li D, Savica R, Low PA, Singer W, Larsen PA, Park HY, Oh SH

Blood-Based Nanoparticle-Enhanced Quaking-Induced Conversion (Nano-QuIC): Inhibitor-Resistant Detection of Seeding Activity in Patients Diagnosed with Parkinson's Disease.

Nano Lett. 2024 Nov 1; Epub 2024 Nov 1 PubMed.

PAPER Sokratian A, Zhou Y, Tatli M, Burbidge KJ, Xu E, Viverette E, Donzelli S, Duda AM, Yuan Y, Li H, Strader S, Patel N, Shiell L, Malankhanova T, Chen O, Mazzulli JR, Perera L, Stahlberg H, Borgnia M, Bartesaghi A, Lashuel HA, West AB

Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases.

Sci Adv. 2024 Nov;10(44):eadq3539. Epub 2024 Nov 1 PubMed.

PAPER Morais LH, Boktor JC, MahmoudianDehkordi S, Kaddurah-Daouk R, Mazmanian SK

α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice.

NPJ Parkinsons Dis. 2024 Oct 30;10(1):208. PubMed.

PAPER Puy L, Barus R, Pasi M, Pétrault M, Deramecourt V, Cordonnier C, Bérézowski V

Distinct neuroinflammatory patterns between cerebral microbleeds and microinfarcts in cerebral amyloid angiopathy.

Ann Clin Transl Neurol. 2024 Nov 4; Epub 2024 Nov 4 PubMed.

PAPER Sin MK, Cheng Y, Ahmed A, Roseman JM, Dowling NM, Zamrini E

Cerebral Amyloid Angiopathy, Dementia, and Alzheimer Neuropathologic Changes: Findings From the ACT Autopsy Cohort.

Neurology. 2024 Nov 26;103(10):e210009. Epub 2024 Oct 31 PubMed.

PAPER Wang J, Wen S, Liu W, Meng X, Jiao Z

Deep joint learning diagnosis of Alzheimer's disease based on multimodal feature fusion.

BioData Min. 2024 Nov 5;17(1):48. PubMed.

PAPER Hong CT, Chen JH, Hu CJ

Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease.

J Biomed Sci. 2024 Nov 5;31(1):102. PubMed.

PAPER Wang W, Min J, Luo Q, Gu X, Li M, Liu X

Lysine Acetyltransferase TIP60 Restricts Nerve Injury by Activating IKKβ/SNAP23 Axis-Mediated Autophagosome-Lysosome Fusion in Alzheimer's Disease.

CNS Neurosci Ther. 2024 Nov;30(11):e70095. PubMed.

PAPER Zhang QY, Wang Q, Fu JX, Xu XX, Guo DS, Pan YC, Zhang T, Wang H

Multi Targeted Therapy for Alzheimer's Disease by Guanidinium-Modified Calixarene and Cyclodextrin Co-Assembly Loaded with Insulin.

ACS Nano. 2024 Nov 5; Epub 2024 Nov 5 PubMed.

PAPER Liampas I, Siokas V, Stamati P, Zoupa E, Tsouris Z, Provatas A, Kefalopoulou Z, Chroni E, Lyketsos CG, Dardiotis E

Motor signs and incident dementia with Lewy bodies in older adults with mild cognitive impairment.

J Am Geriatr Soc. 2024 Nov 5; Epub 2024 Nov 5 PubMed.

PAPER Logroscino G, Urso D, Gnoni V, Giugno A, Vilella D, Castri A, Barone R, Nigro S, Zecca C, De Blasi R, Introna A

Mild cognitive impairment and early Alzheimer's disease eligibility for disease modification therapies in a tertiary centre for cognitive disorders: A simultaneous real-word study on aducanumab and lecanemab.

Eur J Neurol. 2024 Nov 5;:e16534. Epub 2024 Nov 5 PubMed.

PAPER Lim AW, Schneider L, Loy C

Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.

Cochrane Database Syst Rev. 2024 Nov 5;11:CD001747. PubMed.

PAPER Lv X, Zhan L, Ye T, Xie H, Chen Z, Lin Y, Cai X, Yang W, Liao X, Liu J, Sun J

Gut commensal Agathobacter rectalis alleviates microglia-mediated neuroinflammation against pathogenesis of Alzheimer disease.

iScience. 2024 Nov 15;27(11):111116. Epub 2024 Oct 5 PubMed.

PAPER Khan ZA, Waqar M, Chaudhary NI, Raja MJ, Khan S, Khan FA, Chaudhary II, Raja MA

Fractional gradient optimized explainable convolutional neural network for Alzheimer's disease diagnosis.

Heliyon. 2024 Oct 30;10(20):e39037. Epub 2024 Oct 9 PubMed.

PAPER Sonsungsan P, Aimauthon S, Sriwichai N, Namchaiw P

Unveiling mitochondria as central components driving cognitive decline in alzheimer's disease through cross-transcriptomic analysis of hippocampus and entorhinal cortex microarray datasets.

Heliyon. 2024 Oct 30;10(20):e39378. Epub 2024 Oct 15 PubMed.